|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Product sales, net | |||||
| License revenue | |||||
| Total revenue | |||||
| Operating expenses: | |||||
| Cost of sales | |||||
| Selling, general and administrative | |||||
| Research and development | |||||
| General and administrative | |||||
| Restructuring and impairment costs | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income: | |||||
| Other (expense) income | |||||
| Loss on disposal of assets | |||||
| Other expense, net | |||||
| Interest income | |||||
| Total other income, net | |||||
| Net loss before income taxes | |||||
| Income tax expense | |||||
| Net loss | |||||
| Other comprehensive income (loss): | |||||
| Unrealized gain on marketable securities | |||||
| Comprehensive loss | |||||
| Comprehensive loss | |||||
| Net loss per share - basic (in dollars per share) | |||||
| Net loss per share - diluted (in dollars per share) | |||||
| Weighted-average common shares outstanding, basic (in shares) | |||||
| Weighted-average common shares outstanding, diluted (in shares) | |||||
Loading...